LEXICON PHARMACEUTICALS, INC. cotiza a 1.61 USD y tiene una capitalización bursátil de $714M. En los últimos 12 meses ha facturado $41M con un margen de flujo de caja libre del -136.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUI…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.06 | — | $-0.04 |
| Estimado | $-0.05 | $-0.05 | $-0.04 | $-0.07 |
| Sorpresa | — | -20.0% | — | +42.9% |
| Métrica | LXRX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 99.5% | 57.0% | +42.4% |
| Operating Margin | -98.2% | -38.6% | -59.6% |
| Net Margin | -101.1% | -33.6% | -67.5% |
| FCF Margin | -136.2% | -13.9% | -122.4% |
| ROE | -46.8% | -40.4% | -6.4% |
| ROA | -27.2% | -32.0% | +4.8% |
| Current Ratio | 4.88 | 2.84 | +2.04 |
| Debt / Equity | 0.46 | 0.28 | +0.18 |